About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

Under recommendations released Tuesday night, obesity would no longer be defined solely by BMI, a calculation of height and ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...

New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...